Mark W. Reynolds - 05 Jun 2025 Form 4 Insider Report for GeoVax Labs, Inc. (GOVX)

Role: CFO
Signature: /s/ Mark W. Reynolds
Issuer symbol: GOVX
Transactions as of: 05 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Jun 2025, 09:38:09 UTC
Previous filing: 31 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Reynolds Mark	CFO	1900 LAKE PARK DRIVE, SUITE 380, SMYRNA	/s/ Mark W. Reynolds	06 Jun 2025	0001298237

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GOVX	Stock Option	Award	$0	+70,000		$0.000000	70,000	05 Jun 2025	Common Stock	70,000	$2.48	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.
F2	This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan. Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.

Content

Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan. Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.